Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare
Clinical trial NCT05936268 · COMPLETED
Trial details
- NCT number
- NCT05936268
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-21
- Primary completion
- 2024-02-28
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.